Safety, pharmacodynamics, and exposure-response modeling results from a first in human phase 1 study of nedosiran in primary hyperoxaluria.
出版年份 2021 全文链接
标题
Safety, pharmacodynamics, and exposure-response modeling results from a first in human phase 1 study of nedosiran in primary hyperoxaluria.
作者
关键词
chronic kidney disease, gene expression, hyperoxaluria, pediatric nephrology, pharmacokinetics, urology
出版物
KIDNEY INTERNATIONAL
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-09-02
DOI
10.1016/j.kint.2021.08.015
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2
- (2021) Prince Singh et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Hepatic Lactate Dehydrogenase A is an RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria
- (2021) Gema Ariceta et al. Kidney International Reports
- A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3
- (2021) Cristina Martin-Higueras et al. KIDNEY INTERNATIONAL
- Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
- (2021) Sander F. Garrelfs et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endpoints for Clinical Trials in Primary Hyperoxaluria
- (2020) Dawn S. Milliner et al. Clinical Journal of the American Society of Nephrology
- Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity
- (2019) Kyle D. Wood et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up
- (2019) Sander F. Garrelfs et al. KIDNEY INTERNATIONAL
- Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria
- (2018) Chengjung Lai et al. MOLECULAR THERAPY
- Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure
- (2015) F. Zhao et al. Clinical Journal of the American Society of Nephrology
- Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria
- (2015) K. Hopp et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Renal function can be impaired in children with primary hyperoxaluria type 3
- (2015) Lise Allard et al. PEDIATRIC NEPHROLOGY
- Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type
- (2014) Giorgia Mandrile et al. KIDNEY INTERNATIONAL
- NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy
- (2013) Felix Knauf et al. KIDNEY INTERNATIONAL
- Primary Hyperoxaluria
- (2013) Pierre Cochat et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hereditary causes of kidney stones and chronic kidney disease
- (2013) Vidar O. Edvardsson et al. PEDIATRIC NEPHROLOGY
- An update on primary hyperoxaluria
- (2012) Bernd Hoppe Nature Reviews Nephrology
- Primary Hyperoxaluria Type III Gene HOGA1 (Formerly DHDPSL) as a Possible Risk Factor for Idiopathic Calcium Oxalate Urolithiasis
- (2011) C. G. Monico et al. Clinical Journal of the American Society of Nephrology
- Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III
- (2010) Ruth Belostotsky et al. AMERICAN JOURNAL OF HUMAN GENETICS
- New Equations to Estimate GFR in Children with CKD
- (2009) G. J. Schwartz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Genotype–phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome
- (2009) Jérôme Harambat et al. KIDNEY INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now